We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

102 hedge funds and large institutions have $148M invested in Sciclone Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

1% more capital invested

Capital invested by funds: $147M → $148M (+$983K)

2% less funds holding

Funds holding: 104 → 102 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

Holders
102
Holders Change
-2
Holders Change %
-1.92%
% of All Funds
3.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
41
Reduced
34
Closed
16
Calls
$304K
Puts
–
Net Calls
+$304K
Net Calls Change
+$403K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.2M
2
AL
AJO LP
Pennsylvania
+$3.55M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.06M
4
BA
BlackRock Advisors
Delaware
+$2.02M
5
BFA
BlackRock Fund Advisors
California
+$1.49M

Top Sellers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$11.4M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$2.29M
3
TC
TFS Capital
Pennsylvania
-$1.81M
4
Franklin Resources
Franklin Resources
California
-$1.58M
5
Morgan Stanley
Morgan Stanley
New York
-$1M
Name Holding Trade Value Shares
Change 		Change in
Stake
WBC
101
Westpac Banking Corp
Australia
– -$876K -190,517 Closed
ACI
102
AMP Capital Investors
Australia
– -$741K -144,600 Closed
ACM
103
Ativo Capital Management
Illinois
– -$370K -74,545 Closed
SCM
104
Sterling Capital Management
North Carolina
– -$325K -65,435 Closed
First Trust Advisors
105
First Trust Advisors
Illinois
– -$314K -63,375 Closed
RG
106
Renaissance Group
Kentucky
– -$208K -41,953 Closed
Nomura Holdings
107
Nomura Holdings
Japan
– -$159K -32,225 Closed
WCM
108
Wedge Capital Management
North Carolina
– -$105K -21,125 Closed
QI
109
QS Investors
New York
– -$72K -14,500 Closed
ZCM
110
Zebra Capital Management
Connecticut
– -$65K -13,139 Closed
EMG
111
Ellington Management Group
Connecticut
– -$65K -13,100 Closed
RCM
112
Rotella Capital Management
Washington
– -$61K -12,255 Closed
Citadel Advisors
113
Citadel Advisors
Florida
– -$58K -11,594 Closed
EWM
114
Evercore Wealth Management
New York
– -$40K -8,000 Closed
Creative Planning
115
Creative Planning
Kansas
– -$5K -1,000 Closed
Group One Trading
116
Group One Trading
Illinois
– -$5.02K -901 Closed
1 2 3 4
5

SCLN Hedge Fund Activity: Q3 2013 in Review

102 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2013, worth a combined $148M — up 0.67% from $147M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of SCLN and 14 opened new positions — a net loss of 2 holders — while 34 trimmed existing stakes and 41 added.

The largest buyer was Acadian Asset Management, adding an estimated $4.2M. The largest seller was Schroder Investment Management Group, cutting an estimated $11.4M.

  • 102 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2013, down from 104 in Q2 2013.
  • Funds reported $148M of Sciclone Pharmaceuticals Inc stock for Q3 2013, up 0.67% quarter-over-quarter.
  • 14 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2013 and 16 closed out, a net change of -2 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2013 was Acadian Asset Management, an estimated $4.2M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2013 was Schroder Investment Management Group, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2013.